|
1.
|
2019/11/26
|
|
Clinicopathological relevance of tumor expression of NK group 2 member D ligands in resected non-small cell lung cancer
|
|
2.
|
2019/08
|
|
Effects of serratus plane block and epidural analgesia on stress hormones after thoracoscopic lung surgery: a randomized trial.
|
|
3.
|
2019/12/01
|
|
Serum Antibody against NY-ESO-1 and XAGE1 Antigens Potentially Predicts Clinical Responses to Anti-Programmed Cell Death-1 Therapy in NSCLC.
|
|
4.
|
2019/08
|
|
Effect of platinum-based chemotherapy on the expression of natural killer group 2 member D ligands, programmed cell death-1 ligand 1 and HLA class I in non-small cell lung cancer
|
|
5.
|
2019/05
|
|
Comparative study of the PD-L1 expression and CD8+ tumor-infiltrating lymphocyte between surgically resected and matched re-biopsy specimens in recurrent non-small cell lung cancer
|
|
6.
|
2018/10
|
|
Deciduoid type malignant pleural mesothelioma: a case report
|
|
7.
|
2018/09
|
|
Epithelial-mesenchymal transition-induced metastasis could be a bait for natural killer cells
|
|
8.
|
2018/08
|
|
Impact of COX2 Inhibitor for Regulation of PD-L1 Expressioin in Non-small Cell Lung Cancer
|
|
9.
|
2017/10
|
|
Prognostic value of Cox-2 and PD-L1 expression and its relationship with tumor-infiltrating lymphocytes in resected lung adenocarcinoma.
|
|
10.
|
2017/08
|
|
Urinary levels of prostaglandin E2 are positively correlated with intratumoral infiltration of Foxp3+ regulatory T cells in non-small cell lung cancer.
|
|
11.
|
2016/12
|
|
Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings
|
|
12.
|
2015/09
|
|
Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer
|
|
13.
|
2015/09
|
|
Prognostic nutritional index before adjuvant chemotherapy predicts chemotherapy compliance and survival among patients with non-small cell lung cancer
|
|
14.
|
2015/08
|
|
Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer.
|
|
15.
|
2015/01
|
|
Cyclooxygenase-2 genetic variants influence intratumoral infiltration of Foxp3-positive regulatory T cells in non-small cell lung cancer.
|
|
16.
|
2015/02
|
|
Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy.
|
|
17.
|
2014/11
|
|
Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma.
|
|
18.
|
2014/05
|
|
Histological comparison between preoperative and surgical specimens of non-small cell lung cancer for distinguishing between "squamous" and "non-squamous" cell carcinoma.
|
|
19.
|
2013/12
|
|
Lung cancer with sarcoid reaction in the lymph nodes following chemoradiotherapy
|
|
20.
|
2013/07
|
|
Clinical significance of the tumor microenvironment in non-small cell lung cancer
|
|
21.
|
2013/11
|
|
Heterogeneity of the EGFR mutation status between the primary tumor and metastatic lymph node and the sensitivity to EGFR tyrosine kinase inhibitor in non-small cell lung cancer
|
|
22.
|
2012/09
|
|
Characteristics of Non-Small Cell Lung Cancer Located in the Right Middle Lobe According to a Retrospective Study of Recurrence and Prognosis
|
|
23.
|
2012/07
|
|
Membrane-bound Estrogen Receptor-alpha Expression and Epidermal Growth Factor Receptor Mutation are Associated with a Poor Prognosis in Lung Adenocarcinoma Patients
|
|
24.
|
2012/02
|
|
Maximal Standardized Uptake Value on FDG-PET Is Correlated With Cyclooxygenase-2 Expression in Patients With Lung Adenocarcinoma
|
|
25.
|
2011/10
|
|
Interstitial lung disease after re-administration of gefitinib in a responder with no adverse effects during the first administration: a case report
|
|
26.
|
2010/10
|
|
Induction Chemoradiation Therapy with Cisplatin plus Irinotecan Followed by Surgical Resection for Superior Sulcus Tumor
|
|
27.
|
2010/11
|
|
A case of simultaneous lung cancer and abdominal aortic aneurysm treated with a two-stage strategy
|
|
28.
|
2010/05
|
|
Tumor-Infiltrating Foxp3+ Regulatory T Cells are Correlated with Cyclooxygenase-2 Expression and are Associated with Recurrence in Resected Non-small Cell Lung Cancer
|
|
29.
|
2008/12
|
|
Long Survial after Resection for Lung Metastasis of Malignant Peripheral Nerve Sheath Tumor in Neurofibromatosis 1
|
|
30.
|
2008/06
|
|
Recent results regarding the clinical impact of smoking history on postoperative complications in lung cancer patients
|
|
31.
|
2008/07
|
|
Teratoma with malignant transformation in the anterior mediastinum.
|
|
32.
|
2006/02
|
|
Percutaneous CT-guided fine needle aspiration for lung cancer smaller than 2cm and revealed by ground-glass opacity at CT
|
|
33.
|
2005/09
|
|
Clinical Evaluation of Low-dose Cisplatin and 5-Fluorouracil as Adjuvant Chemoradiotherapy for Advanced Squamous Cell Carcinoma of the Esophagus
|
|
34.
|
2024/07/30
|
|
Predictive Value of PERCIST for Locally Advanced Non-Small Cell Lung Cancer Treated with Preoperative Induction Therapy – A Multicenter Study in Japan
|
|
35.
|
2023/11/10
|
|
A case of an atypical variant of type A thymoma presenting with a gradually enlarging tumor over a 10-year period
|
|
36.
|
2023/11/01
|
|
INFORMED CONSENT IN SURGERY FOR PRIMARY LUNG CANCER
|
|
37.
|
2023/01/11
|
|
Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers
|
|
38.
|
2021/11
|
|
Tumor PD-L1 and VEGF Expression, and CD8 T Cell Infiltration Predict Clinical Response to Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
|
|
39.
|
2021/08/06
|
|
The biological Characteristics of Solid Components are Different between Part-Solid-Type and Solid-Type in Lung Adenocarcinoma
|
|
40.
|
2021/05/24
|
|
Pulmonary Resection of the Primary Tumor for Patients with Stage IV Non-Small-Cell Lung Cancer
|
|
41.
|
2021/01/24
|
|
Tofacitinib overcomes an IFNγ‐induced decrease in NK cell‐mediated cytotoxicity via the regulation of immune‐related molecules in LC‐2/ad
|
|
42.
|
2020/09/01
|
|
Perioperative Therapy for Non-Small Cell Lung Cancer - Current Status and Future Perspective -
|
|
43.
|
2017/07
|
|
PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer.
|
|
44.
|
2016/06
|
|
Pneumatosis intestinalis after gefitinib therapy for pulmonary adenocarcinoma: a case report.
|
|
45.
|
2016/03
|
|
MHC class I chain-related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non-small-cell lung cancer
|
|
46.
|
2015/12
|
|
Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells.
|
|
47.
|
2015/10
|
|
Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells
|
|
48.
|
2014/04
|
|
A case report of intrapulmonary schwannoma.
|
|
49.
|
2014
|
|
Clinical significance of vascular endothelial growth factor and Delta-like ligand 4 in small pulmonary adenocarcinoma
|
|
50.
|
2013/11
|
|
Case of pleural metastasis of prostate cancer.
|
|
51.
|
2013/09
|
|
Unknown primary large cell neuroendocrine carcinoma (LCNEC) in the mediastinum.
|
|
52.
|
2013/07
|
|
Role of 2-[18F]Fluoro-2-deoxyglucose positron emission tomography in Preoperative Management of Solid-Type Small-Sized Lung Cancer
|
|
53.
|
2013/02
|
|
Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant
chemotherapy
|
|
54.
|
2013/01
|
|
Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis
|
|
55.
|
2013
|
|
CT, MRI, and 18F-FDG PET-CT findings of pulmonary benign metastasizing leiomyoma: A case report
|
|
56.
|
2012/12
|
|
Current status of Radiologic Diagnosis for Mediastinal
Lymph Node Metastases of Non-Small-Cell Lung Cancer:
Retrospective Study of pN2 Cases
|
|
57.
|
2012/12
|
|
Successful Two-Stage Surgical Treatment for Lung Cancer in a Patient with Contralateral Giant Emphysematous Bullae
|
|
58.
|
2010/08
|
|
Suggestive synchronous triple squamous cell carcinoma of the lung in the same lobe
|
|
59.
|
2010/04
|
|
Pulmonary Apical Mass,the So-Called Pulmonary Apical Cap,in a 43-Year-Old Woman
|
|
60.
|
2008
|
|
Pappillary Fibroelastoma Developing from the Left Ventricular Septum
|
|
61.
|
2007/05
|
|
Paclitaxel and cisplatin with concurrent radiotherapy followed by surgery in locally advanced thymic carcinoma.
|
|
62.
|
2007
|
|
Pure red cell aplasia and myasthenia gravis with recurrent thymoma.
|
|
63.
|
2003/11
|
|
Locoregional immunotherapy of malignant effusion from colorectal cancer using the streptococcal preparation OK-432 plus interleukin-2: Induction of autologous tumor-reactive CD4+ Th1 killer lymphocytes.
|
|
Display 5 items
|
|
Display all(63)
|
